98%
921
2 minutes
20
Asymptomatic bacterial colonization of the urinary bladder (asymptomatic bacteriuria, ABU) can prevent bladder colonization by uropathogens and thus symptomatic urinary tract infection (UTI). Deliberate bladder colonization with ABU isolate 83972 has been shown to outcompete uropathogens and prevent symptomatic UTI by bacterial interference. Many ABU isolates evolved from uropathogenic ancestors and, although attenuated, may still be able to express virulence-associated factors. Our aim was to screen for efficient and safe candidate strains that could be used as alternatives to 83972 for preventive and therapeutic bladder colonization. To identify ABU strains with minimal virulence potential but maximal interference efficiency, we compared nine ABU isolates from diabetic patients regarding their virulence- and fitness-associated phenotypes , their virulence in a murine model of sepsis and their genome content. We identified strains in competitive growth experiments, which successfully interfere with colonization of ABU isolate 83972 or uropathogenic strain 536. Six isolates were able to outcompete 83972 and two of them also outcompeted UPEC 536 during growth in urine. Superior competitiveness was not simply a result of better growth abilities in urine, but seems also to involve expression of antagonistic factors. Competitiveness in urine did not correlate with the prevalence of determinants coding for adhesins, iron uptake, toxins, and antagonistic factors. Three ABU strains (isolates 61, 106, and 123) with superior competitiveness relative to ABU model strain 83972 display low virulence in a murine sepsis model, and susceptibility to antibiotics. They belong to different phylogroups and differ in the presence of ExPEC virulence- and fitness-associated genes. Importantly, they all lack marked cytotoxic activity and exhibit a high LD50 value in the sepsis model. These strains represent promising candidates for a more detailed assessment of relevant fitness traits in urine and their suitability for therapeutic bladder colonization.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817090 | PMC |
http://dx.doi.org/10.3389/fmicb.2018.00214 | DOI Listing |
Nat Commun
September 2025
Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Carbapenem-resistant Enterobacterales pose a critical global health threat, exemplified by increasing resistance of uropathogenic E. coli (UPEC) that cause urinary tract infections (UTIs). Here, we investigate the publicly available EnteroBase dataset and identify a signal of increasing UTI caused by phylogroup A E.
View Article and Find Full Text PDFCurr Opin Obstet Gynecol
August 2025
Department of Urogynecology, Hartford Hospital, Hartford, Connecticut, USA.
Purpose Of Review: The vaginal microbiome plays an important role in protecting the vagina and bladder from infection. There is significant interest in understanding whether probiotics can normalize the vaginal microbiome and lead to decreased incidence of vulvovaginal-associated infections. Probiotics are an appealing treatment option as they are well tolerated, have a low risk profile, and potentially can reduce antibiotic usage.
View Article and Find Full Text PDFBMC Microbiol
August 2025
Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Microbiology Section, P. le Aldo Moro 5, Rome, 00185, Italy.
Background: Uropathogenic Escherichia coli (UPEC) strains are the major causative agents of human urinary tract infections (UTIs). Many patients who develop UTIs will experience a recurrent UTI (RUTI) within 6 months despite antibiotic-mediated clearance of the initial infection. A significant proportion of RUTIs are caused by E.
View Article and Find Full Text PDFbioRxiv
August 2025
Division of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN.
Individuals with neurogenic bladder are particularly susceptible to both chronic bacterial colonization of the bladder and urinary tract infections (UTIs). Neurogenic bladder can arise from a variety of diseases such as diabetes, spinal cord injuries, and spina bifida. To study the ecological and evolutionary dynamics of the microbiome in neurogenic bladder, we developed a longitudinal cohort of 77 children and young adults with spina bifida from two medical centers.
View Article and Find Full Text PDFCureus
July 2025
General Internal Medicine, Toyama University Hospital, Toyama, JPN.
Enterovesical fistula (EVF) is a rare condition that can be difficult to diagnose due to its nonspecific symptoms, such as recurrent urinary tract infections (UTIs), pneumaturia, and fecaluria. We report a case of EVF in which early diagnosis was facilitated by clinically integrated interpretation of urine Gram stain findings in the context of the patient's overall presentation. An 89-year-old woman with a history of rheumatoid arthritis and long-term corticosteroid use presented with fever and right knee pain, initially suspected to be a rheumatoid flare.
View Article and Find Full Text PDF